Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-047020
Filing Date
2015-02-12
Accepted
2015-02-12 17:06:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 LIGAND PHARMACEUTICALS INC d872749dsc13ga.htm SC 13G/A 40214
  Complete submission text file 0001193125-15-047020.txt   41706
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 15607366
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BUSH STREET SUITE 900 SAN FRANCISCO CA 94104
Business Address ONE BUSH STREET SUITE 900 SAN FRANCISCO CA 94104 4155912700
RS INVESTMENT MANAGEMENT CO LLC (Filed by) CIK: 0001085256 (see all company filings)

EIN.: 943321067
Type: SC 13G/A